Piper Sandler

Congratulations to Paragon 28 on their recently announced sale to Zimmer Biomet, anticipated to close in the first half of 2025. Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic segment and is dedicated to improving patient lives. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent and reproducible.   Learn more about the Piper Sandler healthcare team: https://lnkd.in/gvR_WrXv J.P. Peltier, Bart Federak, Daniel Schkrohowsky

Jeremy Goebel, the head of U.S. Government bond trading at Piper Sandler, sits down with The Minnesota Star Tribune to discuss the bond market.

Piper Sandler is excited to announce our eleventh Bi-Annual Cultural Leadership Award recipient: Karin Renier. The award highlights the individuals in our firm who act as a cultural ambassador by consistently demonstrating inclusive partnership, drive, positivity and creativity through an entrepreneurial spirit. “Karin creates space for others to lead confidently, encouraging innovation and exploration. She enables growth and development at every level by putting individuals in a position to succeed,” said a colleague. Congratulations Karin!

We are proud to celebrate our consumer team’s success in 2024 and are excited about the momentum heading into 2025! Learn more about us at pipersandler.com/consumer Damon Chandik, Janica Lane, Melissa French Nilsson, Jon Hjelm, Robert Iseman, Kevin Krouse, Alastair Mathieson, Simon Milne, Dan Oxenham, Dean Pimenta, Thomas Ragsdale, Matt Roghair, Carlos Sanchez, Brian Smith, Abe Thomas, Damian Thornton, John Twichell, Kimberly Wasley

Piper Sandler is excited to announce our new podcast, “What’s Next for Markets,” with chief investment strategist and head of portfolio strategy, Michael Kantrowitz, CFA, and head of quantitative research, Stephen Gregory. When it comes to equity markets, there is a seller for every buyer. But how do you know which side of the trade to be on? Macro trends explain 70% of stock movements so understanding the macro backdrop is essential. Join Michael Kantrowitz, No. 1 ranked Wall Street investment strategist, and the rest of the portfolio strategy & quantitative research team at Piper Sandler as they discuss current macro trends and what’s next for markets. Michael, Stephen, Emily, Joe and Dan have been working together for over 15 years. They pride themselves on their knowledge of financial market history while offering value added research and time-saving resources to their clients. The team utilizes the H.O.P.E. framework (Housing, Orders, Profits & Employment), a proven business cycle analysis to guide listeners through investment decisions and manage risk/reward in global equity markets. When they aren’t advising the best and brightest on Wall Street, they share bad taste in movies and good taste in cuisine. Listen now: https://lnkd.in/gjJDvTYu Join us every Sunday for a new episode and visit https://lnkd.in/gK546dZT to learn more.

Our leading healthcare investment banking platform closed 78 transactions in 2024. Thank you to our valued healthcare clients for your continued support and the trust you place in us to provide valuable, tailored advice. We look forward to partnering with you in 2025 and beyond. View our 2024 healthcare transactions and learn more below. https://lnkd.in/g4UiYQmr

We are excited to announce that Piper Sandler has achieved a score of 100 on the Human Rights Campaign Foundation’s 2025 Corporate Equality Index for the third year! This recognition reflects the values we uphold every day: ensuring that all employees feel respected, supported and empowered to succeed. We are proud to stand alongside other organizations committed to creating fair and inclusive workplaces. Thank you for making Piper Sandler a place where everyone can thrive. View our results: https://lnkd.in/geqVRmgF The Human Rights Campaign Foundation’s Corporate Equality Index is the national benchmarking tool on corporate policies, practices and benefits pertinent to lesbian, gay, bisexual, transgender and queer employees.

Piper Sandler is pleased to announce the addition of John Kerins as a managing director to the healthcare investment banking team. Kerins will continue to serve and support clients within the pharma services sector from the firm’s New York office.   “We are excited to welcome John to the team. His transaction experience combined with strong relationships across the pharma services landscape and with the leading healthcare private equity funds investing in the category are highly complementary to our healthcare investment banking practice. Pharma services is a rapidly growing segment of the market and a key focus for our healthcare investment banking platform. We are confident John’s skillset will enhance our ability to serve our clients and position Piper Sandler for long-term success in this market,” said J.P. Peltier, global group head of healthcare investment banking at Piper Sandler. View the press release to learn more: https://lnkd.in/g8pNzp-j

Piper Sandler is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen, to its energy, power & infrastructure investment banking group. These three strategic hires, along with additional junior bankers, highlight a further expansion into the infrastructure sector, which includes not only traditional and renewable energy but also extends into the tech and transportation sectors. "This is an exciting chapter for our global energy, power & infrastructure investment banking team. The addition of Paul, Jeremi and Daniel will bring deep sector expertise in infrastructure to Piper Sandler and act as a natural complement to our well-established and market-leading energy sector investment banking franchise," said James Baker, global co-head of investment banking and capital markets at Piper Sandler. "Paul, Jeremi and Daniel are experienced investment banking professionals bringing over 40 years of experience within the infrastructure space. We are thrilled to have them on the team delivering exceptional client service," said Sanjiv Shah, global co-head of energy, power & infrastructure investment banking at Piper Sandler. View the press release to learn more: https://lnkd.in/gwXqx9M9 

The Piper Sandler biopharma research team recently published its BioInsights 2024 Year in Review. This provides a recap of the six BioInsights deep-dive thematic reports published during 2024. Within, we reviewed emerging trends and innovation in the development of novel therapeutics for obesity, muscle diseases and epilepsy. The reports also examined the rise of antibody-drug conjugates (ADCs) in oncology, cell therapies for autoimmune diseases and gene therapy for rare diseases. During 2024, we profiled 117 different public and private companies in the BioInsights report series.   View the year in review: https://lnkd.in/g26Wr6yM To access any of Piper Sandler’s BioInsights reports or learn more about the #BioInsights report series, please reach out to your Piper Sandler contact or visit https://lnkd.in/gnJKjjzV. #biopharma #biotech #obesity #ADCs #celltherapy #genetherapy